Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 8Breast Neoplasms 7Polycythemia Vera 5Venous Thromboembolism 3Melanoma 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Tobacco Use Disorder 2Thrombocythemia, Essential 2Smoking Cessation 2Rectal Neoplasms 2Prostatic Neoplasms 2Neoplastic Cells, Circulating 2Neoplasms 2Neoplasm Metastasis 2Myeloproliferative Disorders 2Multiple Myeloma 2Lung Neoplasms 2Barrett Esophagus 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Tuberous Sclerosis 1Thromboembolism 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Seizures 1Salivary Gland Neoplasms 1Recurrence 1Primary Myelofibrosis 1Precancerous Conditions 1

Interventions

YF 476 2Specimen Handling 2Aspirin 2obeticholic acid 1Ursodeoxycholic Acid 1Sunitinib 1Spectrum Analysis 1Radiofrequency Ablation 1Proflavine 1Photochemotherapy 1Metformin 1Itraconazole 1Gastroscopy 1Esomeprazole 1Endoscopy, Digestive System 1Endoscopy 1Endoscopic Mucosal Resection 1Dihematoporphyrin Ether 1Dexlansoprazole 1Cetuximab 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Barrett Esophagus × Aspirin × Clear all
NCT02521285 2026-04-29

Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation

National Cancer Institute (NCI)

Phase 2 Active not recruiting
21 enrolled 35 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

NCT00474903 2014-07-02

Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus

National Cancer Institute (NCI)

Phase 2 Completed
122 enrolled 6 charts
Gastrointestinal

Barrett Esophagus, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡